Lipopolysaccharide binding protein participation in cellular activation by LPS

被引:58
作者
Su, GL
Simmons, RL
Wang, SC
机构
[1] UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA
[2] UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA
关键词
CD14; LPS; LBP; soluble CD14; BPI; endotoxin;
D O I
10.1615/CritRevImmunol.v15.i3-4.10
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide binding protein (LBP) is a plasma protein that plays an important intermediary role in host-endotoxin (LPS) interactions. LBP binds with high affinity to the lipid A portion of LPS and then interacts with the monocytic differentiation antigen CD14 to markedly up-regulate TNF-alpha production by mononuclear phagocytes. In the presence of LBP, 100-fold less LPS is required to trigger this cytokine response. LBP has been implicated in the interaction of LPS with both CD14(+) (monocytes, macrophages, neutrophils) and CD14-cells (endothelial and epithelial cells) to promote such varying responses as secretion of cytokines and nitric oxide (NO), expression of adhesion molecules, production of tissue factor, and activation of neutrophils. Non-CD 14-bearing cells, such as endothelial cells, can also respond to LPS through this pathway via the soluble form of CD14, an interaction that is similarly enhanced by LBP. Recently, it has been proposed that LBP cannot only potentiate host responses to LPS but can also facilitate the neutralization of LPS under certain conditions. LBP has been described as acting as a lipoprotein transfer protein facilitating the transfer of LPS both to the target receptor (CD14) and lipoprotein (HDL).
引用
收藏
页码:201 / 214
页数:14
相关论文
共 97 条
[1]  
AIDA Y, 1990, J IMMUNOL, V145, P3017
[2]   ENDOTOXIN-MEDIATED ENDOTHELIAL-CELL INJURY AND ACTIVATION - ROLE OF SOLUBLE CD14 [J].
ARDITI, M ;
ZHOU, J ;
DORIO, R ;
RONG, GW ;
GOYERT, SM ;
KIM, KS .
INFECTION AND IMMUNITY, 1993, 61 (08) :3149-3156
[3]   STRUCTURAL RELATIONSHIP BETWEEN THE SOLUBLE AND MEMBRANE-BOUND FORMS OF HUMAN MONOCYTE SURFACE GLYCOPROTEIN-CD14 [J].
BAZIL, V ;
BAUDYS, M ;
HILGERT, I ;
STEFANOVA, I ;
LOW, MG ;
ZBROZEK, J ;
HOREJSI, V .
MOLECULAR IMMUNOLOGY, 1989, 26 (07) :657-662
[4]   BIOCHEMICAL-CHARACTERIZATION OF A SOLUBLE FORM OF THE 53-KDA MONOCYTE SURFACE-ANTIGEN [J].
BAZIL, V ;
HOREJSI, V ;
BAUDYS, M ;
KRISTOFOVA, H ;
STROMINGER, JL ;
KOSTKA, W ;
HILGERT, I .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (12) :1583-1589
[5]  
BAZIL V, 1991, J IMMUNOL, V147, P1567
[6]   IMMUNOHISTOLOGICAL PATTERNS OF MYELOID ANTIGENS - TISSUE DISTRIBUTION OF CD13, CD14, CD16, CD31, CD36, CD65, CD66 AND CD67 [J].
BORDESSOULE, D ;
JONES, M ;
GATTER, KC ;
MASON, DY .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (03) :370-383
[7]  
BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
[8]   ENHANCEMENT OF MURINE MACROPHAGE BINDING OF AND RESPONSE TO BACTERIAL LIPOPOLYSACCHARIDE (LPS) BY LPS-BINDING PROTEIN [J].
CORRADIN, SB ;
MAUEL, J ;
GALLAY, P ;
HEUMANN, D ;
ULEVITCH, RJ ;
TOBIAS, PS .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (04) :363-368
[9]  
DENTENER MA, 1993, J IMMUNOL, V150, P2885
[10]  
DENTENER MA, 1993, J IMMUNOL, V151, P4258